期刊文献+

磷脂酰肌醇蛋白多糖-3对肝癌细胞增殖和凋亡的影响 被引量:2

Effects of silencing glypican- 3 gene transcription on proliferation and apoptosis of hepatoma cells
下载PDF
导出
摘要 目的探讨shRNA干预磷脂酰肌醇蛋白多糖(GPC)-3基因转录对肝癌细胞增殖和凋亡的影响。方法将GPC-3-shRNA插入pGPU6/GFP/Neo质粒,转染人肝癌HepG2细胞,以Western Blot和荧光定量PCR分别分析GPC-3蛋白和mRNA表达;以MTT法分析HepG2细胞增殖;以流式细胞术、Annexin-V-PE/7-AAD及细胞凋亡-DNA ladder等分析细胞周期及细胞凋亡率。结果 shRNA1转染HepG2细胞,GPC-3 mRNA沉默效率为89.3%,与GPC-3蛋白下调一致;以shRNA转染HepG2细胞,增殖抑制率为71.1%;细胞周期阻滞在G1期,细胞凋亡率达65.6%。结论资料显示shRNA干预GPC-3基因转录,可显著抑制肝癌细胞增殖,促进肝癌细胞凋亡。 Objective To investigate the effects of silencing glypican -3 (GPC -3) gene transcription by shRNA on the proliferation and apoptosis of hepatoma cells. Methods GPC - 3 - shRNA was inserted into pGPU6/GFP/Neo vector, and HepG2 cells were transfected with the vector. The mRNA and protein expression of GPC -3 was measured by fluorescence quantitative PCR and Western blot; the proliferation of HepG2 cells was evaluated by MTT assay; the cell cycle and apoptosis of HepG2 cells were analyzed by flow cytometry, Annexin -V -PE/7 -AAD staining, and apoptotic DNA ladder kit. Results After the HepG2 cells were transfected with GPC -3 -shRNA, the GPC -3 mRNA silencing rate was up to 89.3%, in accordance with the down - regulation of GPC - 3 protein ; the proliferation inhibition rate of HepG2 cells was as high as 71.1% ; the HepG2 cells were arrested in GI phase, and the apoptosis rate of HepG2 cells reached 65.6%. Conclusion Silencing GPC - 3 gene transcription by shRNA can significantly inhibit the proliferation and promote the apoptosis of hepatoma cells.
出处 《临床肝胆病杂志》 CAS 2013年第11期863-866,共4页 Journal of Clinical Hepatology
基金 国家国际科技合作专项(2013DFA32150) 中国及江苏省博士后项目资助(2013M53139 苏人社发2012-468) 江苏省卫生重点项目(K2011002)
关键词 肝细胞 磷脂酰肌醇蛋白聚糖类 基因沉默 细胞凋亡 细胞增殖 carcinoma, hepatocellular glypican gene silencing apoptosis cell proliferation
  • 相关文献

参考文献8

二级参考文献15

共引文献164

同被引文献15

  • 1Liu Z, Yu P, Xiong Y, et al. Significance of CK19, TPO and HBME-1 expression for diagnosis of papillary thyroid carcinoma [J. IntJClinExpMed,2015,8(3):4369-74.
  • 2Paunovic I, Isic T, Havelka M, et al. Combined immunohisto- chemistry for thyroid peroxidase, galectin-3, CK19 and HBME-Iin differential diagnosis of thyroid tumors [ J ]. APMIS, 2012,120 (5) :368 -79.
  • 3Savin S, Cvejic D, Isic T, et ah Thyroid peroxidase immunohisto- chemistry in differential diagnosis of thyroid tumors J ]. Endocr Pathol, 2006 ,17( 1 ) :53 -60.
  • 4Ceyran A B, Senol S, Simsek B C,et al. Role of cd.56 and e-cad- herin expression in the differential diagnosis of papillary thyroid carcinom and suspected follicular-patterned lesions of the thyroid : the prognostic importance of e-cadherin [ J 1. Int J Clin Exp Pathol, 2015,8 (4) : 3670 - 80.
  • 5Mokhtari M, Eftekhari M, Tahririan R, et al. Absent CD56 ex- pression in papillary thyroid carcinoma : a finding of potential diag-nostic value in problematic cases of thyroid pathology [ J ]. J Res Med Sci,2013,18(12) :1046 -50.
  • 6Shahebrahimi K, Madani S H, Fazaeli A R, et al. Diagnostic val- ue of CD56 and nm23 markers in papillary thyroid carcinoma[ J]. Indian J Pathol Microbinl,2013,56 ( 1 ) :2 - 5, E1.
  • 7Demellawy D, Nasr A, Alowami S. Application of CD56, p63 and CK19 ilnmunohistochemistry in the diagnosis of papillary car- cinoma of the thyroid[ J]. Diagn Pathol,2008,3:5.
  • 8Chen M, Li G, Yan J, et aI. Reevaluation of glypican-3 as a sero- logical marker for hepatocellular carcinoma[ J ]. Clin Chim Acta, 2013,423:105 - 11.
  • 9Yamanaka K, Ito Y, Okuyama N, et al. Immunohistochemical study of glypiean 3 in thyroid cancer[J]. Oneology,2007,73(5 - 6) :389 -94.
  • 10叶文静,邢卫斌,秦兰英,王秀丽,高顺强.Survivin和Ki-67在皮肤鳞癌和基底细胞上皮瘤的表达及相关性分析[J].中国皮肤性病学杂志,2010,24(1):20-22. 被引量:4

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部